Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cancer-Associated Myositis: Paraneoplastic syndrome.

European journal of nuclear medicine and molecular imaging·2025

Same author

Hybrid imaging of complicating osteomyelitis in the peripheral skeleton.

Nuclear medicine communications·2021

Same author

The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2021

Same author

From polyuria to renal mass: an unexpected link.

The American journal of medicine·2015

Same author

Multi-modality imaging of transient osteoporosis of the hip.

Acta orthopaedica Belgica·2012

Same author

Prosthetic joint infections: radionuclide state-of-the-art imaging.

European journal of nuclear medicine and molecular imaging·2012

Search research articles

Related Experiment Video

Updated: Jun 27, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Future diagnostic agents.

Filip Gemmel¹, Nicolas Dumarey, Mick Welling

¹Department of Nuclear Medicine, KCL, Medical Center, Leeuwarden, The Netherlands. f.gemmel@chello.nl

Seminars in Nuclear Medicine

|November 29, 2008

Summary

Diagnosing infections is challenging. New radiopharmaceuticals targeting microbes show promise for infection imaging and therapy monitoring, though clinical use is still under investigation.

Area of Science:

Nuclear medicine
Infectious disease diagnostics
Radiopharmaceutical development

Background:

Accurate diagnosis of infectious diseases is crucial but challenging.
Current laboratory and imaging tests have limitations in differentiating infection from sterile inflammation.
Existing radiopharmaceuticals often lack specificity for bacterial or fungal infections.

Purpose of the Study:

To review the current state and future potential of diagnostic imaging in infectious diseases.
To highlight the limitations of existing scintigraphic techniques and radiopharmaceuticals.
To explore novel radiolabeled anti-infective agents for specific infection detection.

Main Methods:

Review of current diagnostic modalities including laboratory and imaging tests.

More Related Videos

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Related Experiment Videos

Last Updated: Jun 27, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Discussion of radiopharmaceuticals targeting neutrophil-mediated processes.

Exploration of novel approaches using radiolabeled antibiotics and antimicrobial peptides.

Main Results:

Neutrophil-targeting agents can indicate inflammation but are not infection-specific.
Radiolabeled anti-infective agents show promise in preclinical and pilot studies.
These novel agents could potentially monitor antimicrobial therapy success.

Conclusions:

Directly targeting pathogens with radiolabeled anti-infectives is a promising strategy for infection-specific imaging.
Further research and clinical studies are needed to establish the efficacy of these agents in routine practice.
Radiolabeled anti-infective agents represent a potential advancement in diagnosing and managing infectious diseases.